The Gabrail Cancer Center currently has many Clinical Trial opportunities . For more information and to see if you qualify call Carrie Smith R.N., Director of Research at 330-492-3345 x 208 or  via email

Phase I Study of Intratumoral CAVATAK™ (Coxsackievirus A21) and Pembrolizumab in Subjects with Advanced Melanoma

Observational Study Protocol CA184-143: A Multi-National, Prospective, Observational Study in Patients with Unresectable or Metastatic Melanoma

Return to Clinical Trials at GCC